CNBX Pharmaceuticals Inc. (CNBX) Cost of Revenue (2024)

CNBX Pharmaceuticals (CNBX) has 1 years of Cost of Revenue data on file, last reported at $6220.0 in Q1 2024.

• Quarterly Cost of Revenue changed N/A year-over-year to $6220.0 in Q1 2024, while the trailing twelve-month figure through Feb 2026 was $6220.0 (changed 0.0% YoY) and the FY2023 annual result came in at $1223.0, down 92.35% from the prior year.
• Cost of Revenue held at $6220.0 in Q1 2024.
• In the past five years, Cost of Revenue ranged from a high of $6220.0 in Q1 2024 to a low of $6220.0 in Q1 2024.